In a post hoc analysis, although there was a 2.2% (95% CI: −0.5 to 5.0; P = 0.10) absolute between-group difference in LVEF at 1 year favouring the BMC group, this did not reach statistical significance ( Supplementary material online, Table S2 ).
← all excerpts
A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†.
1
—
—